5. Indefinite-Lived Intangible Assets (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Dec. 31, 2019 |
|
| Indefinite-lived Intangible Assets [Line Items] | |||||
| Carrying value of indefinite-lived intangible asset | $ 9,243,128 | $ 9,243,128 | $ 9,243,128 | ||
| OncoHist [Member] | |||||
| Indefinite-lived Intangible Assets [Line Items] | |||||
| Carrying value of indefinite-lived intangible asset | 9,200,000 | 9,200,000 | $ 9,200,000 | ||
| Impairment of indefinite-lived intangible asset | $ 0 | $ 0 | $ 0 | $ 0 | |
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|